Alvotech Holdings S.A Logo

Alvotech Holdings S.A

ALVO | LU

Overview

Corporate Details

ISIN(s):
LU2458332611
LEI:
222100DCZBOWV5DZ8372
Country:
Luxembourg
Address:
9, RUE DE BITBOURG, L-1273 LUXEMBOURG
Sector:
Health Care
Industry:
Biotechnology

Description

We specialize in making biosimilars – to improve lives by expanding access to affordable biologic medicines. We are purpose-driven and passionate about what we do. We have a deep appreciation for the positive impact biologic medicines have had on health care. From insulin to vaccines to monoclonal antibody cancer therapies, biologic medicines are revolutionizing the way we treat diseases and improve patient lives. It is our aim to broaden the availability of these important biologic medicines to patients around the world by developing and manufacturing high-quality, cost-competitive biosimilars. Our commitment to the promise of biosimilars is foundational to our approach, our culture and the strong sense of purpose that inspires us to work smarter and faster towards this mission. We are driven by passion - if there is a proven biologic medicine, we believe it should be accessible to all patients in need.

Social Media

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-13 15:51
Declaration of Voting Results & Voting Rights Announcements
Notification of Own Shares - Alvotech (Arendt Draft 20240606) BBAF_rev
English 59.4 KB
2025-06-11 22:19
Transaction in Own Shares
Öll bréf afhent kaupendum í hlutafjárútboði Alvotech
Icelandic 5.1 KB
2025-06-11 22:19
Capital/Financing Update
Alvotech's Private Placement Completed with Delivery of SDRs and Shares to Inve…
English 17.2 KB
2025-06-06 14:30
Regulatory News Service
Alvotech tekur þátt í árlegri heilbrigðisráðstefnu Goldman Sachs fjárfestingaba…
Icelandic 5.1 KB
2025-06-06 14:30
Regulatory News Service
Alvotech Participates in the Goldman Sachs Global Healthcare Conference in Miami
English 5.0 KB
2025-05-26 10:01
Directors' Dealings
Notification Managers Transaction - Alvotech - Alvogen Lux Holdings S.à r.l.
English 84.5 KB
2025-05-20 09:24
Directors' Dealings
Managers' Transaction Notification R. Davies (20250516)
English 84.1 KB
2025-05-13 17:44
Regulatory News Service
pdf1278040195305217091
English 84.5 KB
2025-05-12 10:18
Regulatory News Service
Managers' Transaction Notification (20250512)
English 55.7 KB
2025-04-30 20:07
Regulatory News Service
222100DCZBOWV5DZ8372-2024-12-31-en (2)
English 1.3 MB
2025-04-30 20:07
Regulatory News Service
4be7257a-c4d2-4fa3-bc77-2b60162f8a38
English 10.0 MB
2025-01-15 22:00
Directors' Dealings
ATP Holdings ehf. - Managers' Transaction Notification (PCA)
English 49.4 KB
2024-12-30 23:41
Directors' Dealings
pdf5009312744798760428 (1)
English 49.5 KB
2024-10-30 12:30
Earnings Release
Alvotech to Report Financial Result..
Icelandic 3.9 KB
2024-10-30 12:30
Earnings Release
Alvotech to Report Financial Result..
English 5.8 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Nykode Therapeutics ASA Logo Nykode Therapeutics ASA Norway NYKD
Oculis Holding AG Logo Oculis Holding AG Switzerland OCS
ONCODESIGN Logo ONCODESIGN France ALONC
Oncodesign Precision Medicine S.A Logo Oncodesign Precision Medicine S.A France ALOPM
Oncoinvent ASA Logo Oncoinvent ASA Norway OCIN
Oncopeptides Logo Oncopeptides Sweden ONCO
Onxeo Logo Onxeo France ALONX
OPKO Health Inc. Logo OPKO Health Inc. Israel OPK
Oramed Pharmaceuticals Inc. Logo Oramed Pharmaceuticals Inc. Israel ORMP
Oryzon Genomics S.A. Logo Oryzon Genomics S.A. Spain ORY